Role of exosomal miRNAs in brain metastasis affected by radiotherapy

Zihuang Li1, Hongli Yang1, Ling Ye2

  • 1Department of Radiation Oncology, The Second Clinical Medical College of Jinan University, Shenzhen Municipal People's Hospital, 1017 Dongmen North Road, Shenzhen, Guangdong, 518020, China.

Insights

This study identified 35 differentially expressed microRNAs (miRNAs) in plasma exosomes of patients with brain metastasis after radiotherapy. These miRNAs may play a role in cancer-related pathways, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression in oncogenesis and tumor development.
  • Limited research exists on miRNAs in plasma exosomes related to brain metastasis following radiotherapy.

Purpose of the Study:

  • To identify microRNAs (miRNAs) and their target genes in plasma exosomes during brain metastasis development in radiotherapy patients.
  • To explore the role of these miRNAs in cancer-related signaling pathways.

Main Methods:

  • Small RNA sequencing was employed to analyze plasma exosomal miRNAs.
  • Bioinformatic analyses, including Gene Ontology and Kyoto Encyclopedia of Genes and Genomes, were used for target gene annotation and pathway analysis.

Main Results:

  • 35 differentially expressed miRNAs were identified in patients with brain metastasis post-radiotherapy.
  • Enrichment analysis revealed miRNA targets involved in cellular processes and key cancer pathways (e.g., MAPK, PI3K-Akt, Ras signaling).

Conclusions:

  • This pilot study provides novel insights into the function of plasma exosomal miRNAs in brain metastasis pathogenesis after radiotherapy.
  • Identified miRNAs represent potential therapeutic targets, warranting further investigation with larger sample sizes.